Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan

NAV
₹9.3104
+1.82%
(3 Feb)
AUM
587 Cr
TER
0.59%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+16.6%
+16.6%
+16.6%
+14.6%
NA
3Y
+32.8%
+32.8%
+32.8%
+32.8%
NA
5Y
+30.0%
+30.0%
+30.0%
+28.6%
NA
ALL
+12.2%
+12.2%
+12.2%
+16.5%
-6.9%
VOL
20.0%
20.0%
20.0%
20.1%
10.0%
TER
0.8%
0.8%
0.8%
0.9%
0.6%
AUM
₹5,817 Cr
₹5,817 Cr
₹5,817 Cr
₹1,449 Cr
₹587 Cr
INFO
0.61
0.61
0.61
0.82
-0.69
See fund holdings as of 31st Dec
Top holdings
Sun Pharmaceuticals Industries Ltd
7.2%
Mankind Pharma Ltd
7.1%
Cipla Ltd
6.7%
Max Healthcare Institute Ltd Ordinary Shares
5.9%
Abbott India Ltd
4.8%
Apollo Hospitals Enterprise Ltd
4.8%
Aster DM Healthcare Ltd Ordinary Shares
4.7%
Clearing Corporation Of India Ltd
4.5%
Lupin Ltd
4.5%
Divi's Laboratories Ltd
4.4%
Top industry exposure
Healthcare
92.1%
Financial Services
3.3%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
33%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Sanjay Chawla

FAQs